Labcorp Holdings (LH) Cash from Discontinued Operations (2022 - 2023)

Labcorp Holdings (LH) posted Cash from Discontinued Operations of 189900000.0 for Q2 2023, up 394.42% sequentially from 64500000.0 in Q1 2023.

Labcorp Holdings (LH) Cash from Discontinued Operations (2022 - 2023) Analysis & Trends

Labcorp Holdings has reported Cash from Discontinued Operations for 2 years, with the latest figure at 189900000.0 in Q2 2023.

  • Quarterly Cash from Discontinued Operations changed N/A year-over-year to 189900000.0 in Q2 2023, while the trailing twelve-month figure through Mar 2024 was 189900000.0 (changed N/A YoY) and the FY2023 annual result came in at 125400000.0, down 34.38% from the prior year.
  • Cash from Discontinued Operations grew to 189900000.0 in Q2 2023 per LH's latest filing, from 64500000.0 in the prior quarter.
  • Over five years, Cash from Discontinued Operations peaked at 189900000.0 in Q2 2023 and troughed at 64500000.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Thermo Fisher Scientific 213.99 Bn 209.92 Bn 8.34 Bn -
2 Danaher 140.41 Bn 136.06 Bn 3.61 Bn -
3 Idexx Laboratories 46.27 Bn 46.08 Bn 779.09 Mn -
4 Agilent Technologies 39.81 Bn 38.00 Bn 990.00 Mn -
5 Iqvia Holdings 39.53 Bn 37.45 Bn 1.44 Bn -
6 Natera 38.83 Bn 37.73 Bn 696.04 Mn -
7 Illumina 30.03 Bn 28.86 Bn 770.00 Mn -
8 Mettler Toledo International 28.67 Bn 28.62 Bn 650.22 Mn -
9 Quest Diagnostics 26.16 Bn 25.54 Bn 1.03 Bn -
10 Labcorp Holdings 25.89 Bn 24.91 Bn 1.01 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2023 189.90 Mn
Jun 30, 2023 189.90 Mn
Mar 31, 2023 -64.50 Mn
Mar 31, 2023 -64.50 Mn
Dec 31, 2022 46.40 Mn
Dec 31, 2022 46.40 Mn
Sep 30, 2022 120.80 Mn
Sep 30, 2022 120.80 Mn